Scientists from Australia, the US and Europe have identified key genes responsible for fibromuscular dysplasia — or FMD — a vascular disease that affects the arteries and can cause heart attack, kidney complications, stroke and aneurysm.
Artrya's non-invasive diagnostic support solution to detect coronary artery disease has commenced its first market pilot with Perth-based radiology practice Envision Medical Imaging.
The first large-scale, long-term trial of a new strategy using combinations of very low doses in one capsule has demonstrated significantly improved control of high blood pressure.
More than a quarter of a million Australians have faulty heart valves and are at risk of serious complications, and don't know it.
The Global Cardiovascular Research Funders Forum aims to to advance the prevention, diagnosis and treatment of cardiovascular conditions such as heart attack and stroke.
Flinders University has become a research partner of the Freemasons Centre for Male Health & Wellbeing, broadening the scope and footprint of the centre's activities.
Treating high-risk patients with recommended blood pressure and cholesterol-lowering medicines could prevent more than 103,000 heart attacks, strokes and heart-related deaths.
Heart Research Australia is encouraging Australians to wear red and donate during February, to raise awareness for heart disease and funds for life-saving research.
A trial has found that heart attacks and the need for coronary stenting or bypass surgery reduced by 30% in patients taking low-dose colchicine, a drug commonly used to treat gout.
The team of doctors used stereotactic ablative body radiotherapy to treat a patient with a life-threatening arrhythmia known as ventricular tachycardia.
Australians living with symptoms of severe aortic stenosis will now have access to a minimally invasive heart treatment that was previously reserved for only the sickest patients.
A research project underway in western Sydney could see marked improvements for patients with atrial fibrillation.
A University of Newcastle study has revealed that heart patients with a history of cancer are less likely to receive the heart medications they need.
A new heart transplant method means that a donated heart can now be transported and preserved for longer than previously possible.
An Australian-developed anti-clotting drug could treat one of the most devastating, life-threatening complications of COVID-19 — microscopic blood clots.